CATHERINE BARBER: Open Payments
NPI 1427087055 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,281 in 169 payments from 21 companies in 2025. Trend: 2023 $1,033 · 2024 $948 · 2025 $4,281
Food & beverage: $4,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $937 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $466 |
| Janssen Biotech, Inc. | 18 | $440 |
| Madrigal Pharmaceuticals | 7 | $382 |
| Celltrion USA Inc. | 8 | $285 |
| Lilly USA, LLC | 7 | $264 |
| Gilead Sciences, Inc. | 5 | $231 |
| QOL Medical, LLC | 9 | $215 |
| PFIZER INC. | 11 | $188 |
| Ardelyx, Inc. | 7 | $141 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, RINVOQ, SKYRIZI, OMVOH, DUPIXENT, Sucraid.
Industry payments across FL — which companies pay providers there.
